How to Diagnose and Manage QT Prolongation in Cancer Patients
- PMID: 34396315
- PMCID: PMC8352274
- DOI: 10.1016/j.jaccao.2021.01.002
How to Diagnose and Manage QT Prolongation in Cancer Patients
Keywords: ECG, electrocardiogram; QT interval; QTc, QT interval corrected for heart rate; TKI, tyrosine kinase inhibitor; TdP, torsades de pointes; chemotherapy-induced cardiotoxicity; torsades de pointes.
Conflict of interest statement
The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures
References
-
- Giudicessi J.R., Noseworthy P.A., Ackerman M.J. The QT interval. Circulation. 2019;139:2711–2713. - PubMed
-
- National Cancer Institute Common Terminology of Clinical Adverse Events v5.0. National Cancer Institute Division of Cancer Treatment and Diagnosis website. https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs... Published November 27, 2017. Available at: Accessed January 11, 2021.
-
- Rosner M.H., Dalkin A.C. Electrolyte disorders associated with cancer. Adv Chronic Kidney Dis. 2014;21:7–17. - PubMed
-
- Woosley R.L., Heise C.W., Gallo T. QT drugs List. www.crediblemeds.org Available at: Accessed October 20, 2020.
Publication types
LinkOut - more resources
Full Text Sources
